Events & Training

19th Annual Superbugs & Superdrugs

20 March 2017 - 21 March 2017

SMi’s flagship show in its global Superbugs portfolio of events has been expanding horizons on the growing threat of anti-microbial resistance (AMR) and infectious disease for almost two decades. Now in its 19th year, Superbugs & Superdrugs returns to London on 20th and 21st March 2017, providing a focal point for its growing “superbugs” community to exchange novel solutions and consolidate current strategies. Hear from panel of speakers who will hone in on key issues such as funding, animal models in drug research and antimicrobial peptides. Highlights include an exclusive keynote address from the FDA. Featured Speakers: • Sumathi Nambiar, Director, Division of Anti-Infective Products, FDA • Richard Bax, Senior Partner, TranScrip • Lloyd Czaplewski, Director, Chemical Biology Ventures • Chris Houchens, Branch Chief, BARDA • James Anderson, Head of Corporate Government Affairs, GlaxoSmithKline • Aileen Rubio, Head of Biology, Spero Therapeutics • David Williams, Chief Executive Officer, Discuva • Martin Everett, Chief Scientific Officer, ANTABIO SAS • Jean de Gunzburg, Scientific Director, Da Volterra • William J Weiss, Director, Pre-Clinical Services, UNT System College of Pharmacy

Copthorne Tara Hotel, Kensington, London UK

9th Ocular Diseases Drug Discovery Conference

20 March 2017 - 21 March 2017

The 9th Ocular Diseases Drug Discovery Conference is taking place on March 20-21, 2017 in San Diego, CA. We are excited to have top representatives from the industry and academic sectors to discuss technologies and targets that are continually changing the way ocular diseases are treated. Drug delivery is always improving as we look at for better methods to penetrate anterior and poster segments of the eye. Successes in gene therapy and regenerative medicine are proving to be interesting approaches to discuss in detail pre-clinically and clinically. We are gathering leading scientists, researchers, and experts to discuss and collaborate on combating and curing age-related macular degeneration (AMD), dry eye, glaucoma, diabetic macular edema (DME), and other ocular diseases.

Hilton San Diego Resort and Spa, San Diego, CA, USA

Biomarker Summit 2017

20 March 2017 - 22 March 2017

The Biomarker Summit 2017, to be held on March 20-22, 2017 in San Diego, CA at the Hilton San Diego Resort & Spa, is a meeting place for leaders in the field to discuss the issues and challenges scientists and researchers face in all aspects of the biomarker and diagnostic development process from discovery to translation to commercialization. A wide variety of important topics will be covered including biomarker identification, validation, and translation strategies, bioinformatics and systems biology approaches to personalized medicine, big data analytics and management, regulatory and reimbursement trends, companion diagnostics development, and much more. Through scientific presentations, case studies and panel discussions, these areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector. Assembling leading scientists, researchers, decision-makers and other players across the industry spectrum, the Summit provides a unique opportunity to gain the latest biomarker developments in four major therapeutic areas, formally organized in the following tracks:

San Diego Resort and Spa, San Diego, CA, USA

Paediatric Clinical Trials

20 March 2017 - 21 March 2017

Join us as we discuss current clinical trials, implementation and paediatric drug development in a series of interactive conference sessions, roundtables and workshops led by leading industry experts. Gain information on methods to improve clinical recruitment, appreciate ethical issues and navigate regulations when planning and executing a paediatric clinical trial. We will be exploring the complexities of paediatric drug formulation and helping you determine clinical endpoints.

Copthorne Tara Hotel, Kensington, London UK

10th Oncology Biomarkers Conference

20 March 2017 - 22 March 2017

The 10th Oncology Biomarkers Conference is one of four conferences part of the Biomarker Summit 2017 to be held on March 20-22, 2017 in San Diego, CA. This conference brings together experts in industry, academia and government to discuss the latest developments in the oncology biomarker research arena. Hot topics include circulating tumor cells, cell free DNA, digital pathology and imaging biomarkers. Applications of technologies such as mass spectrometry and next generation sequencing as well as data analysis and interpretation will also be discussed. Please join us for the opportunity to listen to recent updates on research, share ideas with colleagues, and network with experts to advance biomarker discovery and development.

Hilton San Diego Resort and Spa, San Diego, CA, USA

BIT's 10th Anniversary of Protein & Peptide Conference, PepCon-2017

22 March 2017 - 24 March 2017

To celebrate BIT's 10th Anniversary of Protein & Peptide Conference, PepCon-2017 will be held during March 22-24, 2017, in Fukuoka, Japan. With 9 years’ conference holding experiences support, as well as variety social events, the PepCon-2017 will attract 400+ Participants from 20+ Countries with 100+ Poster and Exhibition Presentations to join in the grand festival!

Hilton Fukuoka Sea Hawk, Fukuoka, Japan

12th Göttingen Meeting of the German Neuroscience Society

22 March 2017 - 25 March 2017

Geisteswissenschaftliches Zentrum, Göttingen, Germany

Drug Discovery 2017

27 March 2017 - 28 March 2017

Drug Discovery 2017 aims to bridge the gaps in approval for drug discovery and development by discussing the latest scientific breakthroughs, exploring novel technologies and approaches that can be used to overcome drug development challenges. The event will bring togehter industry leaders who will highlight future opportunities for novel therapeutic discovery. Some of our featured speakers include • Lorenz Mayr, VP & Global Head, AstraZeneca • Guido Hanaeur, Scientific Director Translational Medicine, Takeda • Ulrich Schopfer, Executive Director, Head Integrated Lead Discovery, Novartis • Yolanda Chong, Principal Scientist, Johnson & Johnson • Matthias Frech, Director, Molecular Interactions & Biophysics, Merck Serono • Wengard Czechtizky, Head of Chemistry, Sanofi • Ulrich Schopfer, Executive Director, head Integrated Lead Discovery, Novartis • Stephen Pickett, Senior Scientific Investigator, GSK Plus more from AbbVie, UCB Pharma, Eli Lilly, TissUse, Heptares etc. Key Highlights: • AstraZeneca discusses the use of CRISPR/Cas9 Technology in target discovery, hit finding and translational studies • Novartis optimises the success of phenotyping screening • Takeda explores whether translational medicine is capable of increasing success rate in pharma • Gain insights into receptor activation from agonist and antagonist structures with Merck • Discover applications of enabling chemistry technology to the acceleration of the drug discovery process with AbbVie

Holiday Inn Kensington Forum, London, UK

5th Annual Pharma Labeling Compliance Conference

29 March 2017 - 30 March 2017

Join 60+ senior-level executives at this exclusive event, for an intimate networking experience. This conference will discuss strategies and insights needed to develop innovative ways to utilize human factors and usability data represented in the product label, mastering combination product labeling, and strategies to document core content. Hear from Sanofi, AbbVie, Inc., Genetech, Inc., Shire, Eisai, Inc., and more!

Boston, MA, USA

Asthma & COPD 2017

29 March 2017 - 30 March 2017

Aimed at senior scientists and respiratory and inhalation specialists, Asthma & COPD 2017 will reflect on the ongoing issues and latest developments of these two diseases. With a carefully selected panel of industry experts, the 2017 event will address the latest challenges and changes in the fields of asthma and COPD. The agenda will explore novel approaches to treatment, including cutting edge developments in triple combination therapies and phenotyping. As well as identify challenges to device development and delivery, deepen our understanding of the problems relating to these diseases, and discuss the hot topic of electronic health monitoring. Hear from MHRA, Mylan, AstraZeneca, Teva UK, GlaxoSmithKline, Boehringer Ingelheim, Glenmark Pharmaceuticals, Janssen, AstraZeneca, Novartis and many more… Early birds available

Holiday Inn Kensington Forum, London, UK